Bristol Myers Squibb (BMY) financials
Bristol Myers Squibb revenue and earnings by year
Bristol Myers Squibb's revenue was $48.2 billion in the fiscal year to December 31, 2025, down 0.2% from the year before. Net income was $7.05 billion, 14.6% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 10.6% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48.2 | 48.3 | 45.0 | 46.2 | 46.4 | 42.5 | 26.1 | 22.6 | 20.8 | 19.4 |
| Revenue growth | -0.2% | 7.3% | -2.5% | -0.5% | 9.1% | 62.6% | 15.9% | 8.6% | 6.9% | — |
| Gross profit | 34.3 | 34.3 | 34.3 | 36.0 | 36.4 | 30.7 | 18.1 | 16.1 | 14.8 | 14.5 |
| Gross margin | 71.1% | 71.1% | 76.2% | 78.0% | 78.6% | 72.3% | 69.1% | 71.3% | 71.1% | 74.4% |
| Operating income | 9.3 | -8.4 | 8.4 | 7.7 | 8.1 | -6.9 | 5.0 | 6.0 | 5.1 | 5.9 |
| Operating margin | 19.4% | -17.3% | 18.8% | 16.7% | 17.5% | -16.2% | 19.0% | 26.5% | 24.7% | 30.4% |
| Net income | 7.1 | -8.9 | 8.0 | 6.3 | 7.0 | -9.0 | 3.4 | 4.9 | 1.0 | 4.5 |
| Net margin | 14.6% | -18.5% | 17.8% | 13.7% | 15.1% | -21.2% | 13.2% | 21.8% | 4.8% | 22.9% |
| Diluted EPS | $3.46 | -$4.41 | $3.86 | $2.95 | $3.12 | -$4.01 | $2.19 | $3.01 | $0.59 | $2.65 |
| Free cash flow | 12.8 | 13.9 | 12.7 | 11.9 | 15.2 | 13.3 | 7.4 | 6.1 | 4.2 | 1.8 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open BMY in Markets.
See also: BMY valuation and P/E history · BMY returns
No forecast, no recommendation. This page describes Bristol Myers Squibb from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.